Propafenone is a cardiovascular medication used to treat atrial fibrillations, atrial flutters, ventricular tachycardia, and Wolff-Parkinson-White syndrome. Suppliers of propafenone market it in the form of 150mg and 300mg tablets. The drug was first introduced into the market in 1999. Multiple manufacturers of propafenone have since introduced their formulations into the market. Such producers include well-known pharmaceutical companies Mylan, Novartis, Abbott, and Teva. Propafenone suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified propafenone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 50 (150mg) tablets of propafenone fall into an approximate range of 8,00 EUR to 12,00 EUR, whereas the equivalent amount of 300mg tablets can cost anywhere from 14,00 EUR to 18,00 EUR. And 100ml (3.5mg/ml) of propafenone injectable solution costs around 12,00 EUR to 14,00 EUR.